{Reference Type}: Journal Article
{Title}: The relationship between GAD65 autoantibody and the risk of T1DM onset.
{Author}: Keshavarzi E;Noveiry BB;Rezaei N;
{Journal}: J Diabetes Metab Disord
{Volume}: 21
{Issue}: 2
{Year}: Dec 2022
暂无{DOI}: 10.1007/s40200-022-01098-w
{Abstract}: <B>UNASSIGNED: </B>Type 1 diabetes mellitus (T1DM) is a well-known autoimmune disease, characterized by β-cell destruction in pancreas islet cells, which results insulin deficiency and subsequent hyperglycemic sequelae. While there is screening for type 2 DM that leads to better glycemic control and outcome, the majority of T1DM patients are diagnosed when much of the pancreatic cells and their function are disturbed. The aim of this article is to present an overview of the effective factors in the positivity of Glutamic acid decarboxylase antibody )GADA( and identifying the high-risk individuals for T1DM.<BR><B>UNASSIGNED: </B>We searched English literature available at National Library of Medicine via PubMed, and Google Scholar through December 2020. Finally, 79 papers have been included in the study. Studies were summarized based on the number of positive autoantibodies and onset of T1DM over time and GADA correlation with different variables.<BR><B>UNASSIGNED: </B>GADA is an easy marker to measure that can be detected many months prior to the clinical presentation and remains positive even after early childhood.